Financials ResMed, Inc.

Equities

RMD

US7611521078

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 21:00:02 11/12/2025 GMT			5-day change	1st Jan Change
252.39 ^USD	+0.35%		+0.35%	+10.36%

12-09	Resmed Insider Sold Shares Worth $1,254,796, According to a Recent SEC Filing	MT
12-09	Shares of Resmed Fall After Securing FDA Clearance for a Device Recommending Personalized Comfort Settings	MT

Projected Income Statement: ResMed, Inc.

Fiscal Period: June	2021	2022	2023	2024	2025	2026	2027	2028
Net sales ¹	3,197	3,578	4,223	4,685	5,146	5,602	6,021	6,445
Change	-	11.93%	18.02%	10.95%	9.84%	8.86%	7.47%	7.05%
EBITDA ¹	1,074	1,162	1,317	1,576	1,884	2,166	2,355	2,550
Change	-	8.14%	13.38%	19.63%	19.59%	14.93%	8.73%	8.28%
EBIT ¹	903.7	1,000	1,224	1,478	1,763	2,027	2,209	2,387
Change	-	10.69%	22.41%	20.74%	19.27%	14.95%	9%	8.05%
Interest Paid ¹	-23.63	-22.31	-47.38	-45.71	4.114	-1	-1	-
Earnings before Tax (EBT) ¹	883.7	960.5	1,102	1,265	1,678	1,924	2,151	2,364
Change	-	8.69%	14.7%	14.81%	32.64%	14.66%	11.81%	9.93%
Net income ¹	474.5	779.4	897.6	1,021	1,401	1,535	1,708	1,866
Change	-	64.26%	15.15%	13.75%	37.2%	9.62%	11.21%	9.26%
Announcement Date	05/08/21	11/08/22	03/08/23	01/08/24	31/07/25	-	-	-

¹USD in Million

Estimates

Fiscal Period: June	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4
Net sales ¹	800	768.8	876.1	904	894.9	864.5	914.7	950.3	1,034	1,117	1,122	1,102	1,163	1,197	1,223	1,225	1,282	1,292	1,348	1,336	1,397	1,409	1,459	1,434	1,488	1,498	1,551
Change	-	-3.91%	13.96%	3.19%	-1.01%	-3.39%	5.81%	3.89%	8.78%	8.04%	0.46%	-1.76%	5.49%	2.94%	2.19%	0.11%	4.7%	0.75%	4.36%	-0.92%	4.6%	0.87%	3.52%	-1.68%	3.78%	0.61%	3.56%
EBITDA ¹	276.2	263.4	278.4	301	289.5	276.6	294.7	312.8	326.4	345	333	363.7	390.5	418.1	424.9	432	463.7	469.9	518.7	510	550.5	557.5	580.7	569.7	591.5	596.7	611.7
Change	-	-4.63%	5.67%	8.14%	-3.83%	-4.47%	6.54%	6.14%	4.35%	5.72%	-3.49%	9.22%	7.35%	7.07%	1.64%	1.68%	7.32%	1.35%	10.37%	-1.67%	7.93%	1.27%	4.17%	-1.9%	3.83%	0.87%	2.51%
EBIT ¹	221.7	223.4	241.6	261.9	248.7	234.3	255.4	290.8	305.5	321.2	307	318.8	365.5	393.6	400.5	406.4	435.9	444.6	476.4	482.1	506.5	514.5	536.3	531.2	546.1	551.7	569.1
Change	-	0.77%	8.15%	8.39%	-5.04%	-5.81%	9.02%	13.87%	5.04%	5.14%	-4.43%	3.85%	14.66%	7.69%	1.74%	1.48%	7.27%	1.99%	7.14%	1.21%	5.05%	1.58%	4.25%	-0.95%	2.8%	1.03%	3.15%
Charge d'intérêts	-5.792	-5.823	-5.286	-5.36	-5.792	-5.462	-5.542	-7.134	-10.34	-14.96	-14.94	-14.96	-13.8	-11.03	-5.92	-1.661	-0.775	0.793	5.757	8.793	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	210.6	218	239.2	258.8	237.3	226.3	238.1	261.8	273.7	289.4	276.8	272.2	259.5	375.4	357.7	383.5	418.3	417.7	458.1	446.8	491	501.9	520.2	516	538	545	579
Change	-	3.52%	9.73%	8.18%	-8.31%	-4.62%	5.2%	9.96%	4.54%	5.73%	-4.35%	-1.67%	-4.68%	44.7%	-4.71%	7.2%	9.08%	-0.15%	9.66%	-2.46%	9.89%	2.22%	3.65%	-0.81%	4.26%	1.3%	6.24%
Net income ¹	179.5	-78.48	195.1	203.6	201.8	179	195.1	210.5	224.9	232.5	229.7	219.4	208.8	300.5	292.2	311.4	344.6	365	379.7	348.5	384.5	393.1	406.6	400.5	418.5	423	443
Change	-	-143.72%	348.59%	4.36%	-0.91%	-11.27%	8.97%	7.9%	6.86%	3.37%	-1.22%	-4.46%	-4.84%	43.91%	-2.75%	6.54%	10.68%	5.93%	4.02%	-8.21%	10.32%	2.23%	3.44%	-1.49%	4.49%	1.08%	4.73%
Announcement Date	28/01/21	29/04/21	05/08/21	28/10/21	27/01/22	28/04/22	11/08/22	27/10/22	26/01/23	27/04/23	03/08/23	26/10/23	24/01/24	25/04/24	01/08/24	24/10/24	30/01/25	23/04/25	31/07/25	30/10/25	-	-	-	-	-	-	-

¹USD in Million

Estimates

Forecast Balance Sheet: ResMed, Inc.

Fiscal Period: June	2021	2022	2023	2024	2025	2026	2027	2028
Net Debt ¹	360	502	1,213	469	-541	-1,230	-2,094	-3,210
Change	-	39.44%	141.63%	-61.34%	-215.35%	-127.29%	-70.24%	-53.3%
Announcement Date	05/08/21	11/08/22	03/08/23	01/08/24	31/07/25	-	-	-

¹USD in Million

Estimates

Cash Flow Forecast: ResMed, Inc.

Fiscal Period: June	2021	2022	2023	2024	2025	2026	2027	2028
CAPEX ¹	102.7	134.8	119.7	99.46	89.86	156.5	158.5	168.8
Change	-	31.27%	-11.25%	-16.89%	-9.65%	74.2%	1.27%	6.45%
Free Cash Flow (FCF) ¹	634	216.3	573.6	1,302	1,662	1,576	1,694	1,828
Change	-	-65.88%	165.19%	126.94%	27.65%	-5.19%	7.51%	7.93%
Announcement Date	05/08/21	11/08/22	03/08/23	01/08/24	31/07/25	-	-	-

¹USD in Million

Estimates

Forecast Financial Ratios: ResMed, Inc.

Fiscal Period: June	2021	2022	2023	2024	2025	2026	2027	2028
Profitability
EBITDA Margin (%)	33.61%	32.47%	31.19%	33.63%	36.62%	38.66%	39.11%	39.56%
EBIT Margin (%)	28.27%	27.96%	28.99%	31.55%	34.26%	36.18%	36.7%	37.04%
EBT Margin (%)	27.64%	26.84%	26.09%	27%	32.6%	34.33%	35.72%	36.68%
Net margin (%)	14.84%	21.78%	21.25%	21.79%	27.22%	27.41%	28.36%	28.95%
FCF margin (%)	19.83%	6.05%	13.58%	27.78%	32.29%	28.12%	28.13%	28.36%
FCF / Net Income (%)	133.61%	27.75%	63.91%	127.51%	118.63%	102.61%	99.19%	97.99%
Profitability
ROA	16.76%	17.32%	16.03%	16.72%	18.7%	19%	18.92%	18.67%
ROE	29%	27.24%	25.36%	25.33%	25.97%	24.67%	23.9%	22.65%
Financial Health
Leverage (Debt/EBITDA)	0.34x	0.43x	0.92x	0.3x	-	-	-	-
Debt / Free cash flow	0.57x	2.32x	2.12x	0.36x	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	3.21%	3.77%	2.83%	2.12%	1.75%	2.79%	2.63%	2.62%
CAPEX / EBITDA (%)	9.56%	11.61%	9.09%	6.31%	4.77%	7.23%	6.73%	6.62%
CAPEX / FCF (%)	16.2%	62.33%	20.86%	7.64%	5.41%	9.94%	9.36%	9.23%
Items per share
Cash flow per share ¹	5.03	2.388	4.702	9.497	11.89	10.8	11.69	-
Change	-	-52.52%	96.88%	101.98%	25.18%	-9.14%	8.24%	-
Dividend per Share ¹	1.56	1.68	1.8	1.92	-	2.418	2.661	2.895
Change	-	7.69%	7.14%	6.67%	-	-	10.03%	8.79%
Book Value Per Share ¹	19.86	22.42	28.14	33.11	40.77	46.89	54.24	60.09
Change	-	12.91%	25.51%	17.67%	23.13%	15.03%	15.66%	10.8%
EPS ¹	3.24	5.3	6.09	6.92	9.51	10.49	11.63	12.79
Change	-	63.58%	14.91%	13.63%	37.43%	10.29%	10.89%	9.92%
Nbr of stocks (in thousands)	145,640	146,405	147,062	146,884	146,365	145,753	145,753	145,753
Announcement Date	05/08/21	11/08/22	03/08/23	01/08/24	31/07/25	-	-	-